WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CGTX

Based on 2 analysts offering 12 month price targets for Cognition Therapeutics Inc.
Min Forecast
$5.00+159.07%
Avg Forecast
$7.00+262.69%
Max Forecast
$9.00+366.32%

Should I buy or sell CGTX stock?

Based on 2 analysts offering ratings for Cognition Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CGTX stock forecasts and price targets.

CGTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-27

1 of 1

Forecast return on equity

Is CGTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is CGTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CGTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CGTX$1.93$7.00+262.69%Strong Buy
CNTB$1.36$8.00+488.24%Buy
GRTS$0.76$6.00+685.34%Buy
AFMD$4.88$13.33+173.22%Buy
YS$0.80$5.25+560.38%Buy
View Top Biotech Stocks

Cognition Therapeutics Stock Forecast FAQ

Is Cognition Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CGTX) stock is to Strong Buy CGTX stock.

Out of 2 analysts, 1 (50%) are recommending CGTX as a Strong Buy, 1 (50%) are recommending CGTX as a Buy, 0 (0%) are recommending CGTX as a Hold, 0 (0%) are recommending CGTX as a Sell, and 0 (0%) are recommending CGTX as a Strong Sell.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.

What is CGTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CGTX) forecast ROE is N/A, which is considered weak.

What is CGTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CGTX price target, the average CGTX price target is $7.00, with the highest CGTX stock price forecast at $9.00 and the lowest CGTX stock price forecast at $5.00.

On average, Wall Street analysts predict that Cognition Therapeutics's share price could reach $7.00 by Mar 28, 2025. The average Cognition Therapeutics stock price prediction forecasts a potential upside of 262.69% from the current CGTX share price of $1.93.

What is CGTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CGTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.